Nasdaq

Femasys Inc. Announces CE Mark Certification for Innovative FemBloc® Non-Surgical Birth Control Delivery System

Femasys Inc. announced the achievement of CE mark certification for the FemBloc delivery system, marking it as the first regulatory approval in the world for a non-surgical permanent birth control ...
Seeking Alpha

Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (FEMY),, a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, ...
News Medical

Study reveals high failure rate for tubal sterilization as birth control

Tubal sterilization is thought to be a permanent form of birth control and is the most common method of contraception nationally. But a new study led by UC San Francisco reports that tubal surgery ...
Nasdaq

Femasys Inc. Receives CE Mark Certification for Revolutionary FemBloc® System for Non-Surgical Permanent Birth Control

Femasys Inc. has announced the receipt of Conformité Européene (CE) mark certification for its FemBloc blended polymer component, marking the world's first regulatory approval for a non-surgical ...
ABC Kcrg 9

Number of women seeking long-acting birth control, sterilization rises after Trump’s re-election

CEDAR RAPIDS, Iowa (KCRG) - When Donald Trump was first elected in 2016, a study from the National Library of Medicine revealed there was a 21% spike in women seeking long-term birth control. Now that ...